2.29
Precedente Chiudi:
$2.49
Aprire:
$2.3
Volume 24 ore:
1.45M
Relative Volume:
1.73
Capitalizzazione di mercato:
$189.70M
Reddito:
$70.14M
Utile/perdita netta:
$-76.24M
Rapporto P/E:
-2.0631
EPS:
-1.11
Flusso di cassa netto:
$-57.06M
1 W Prestazione:
-21.58%
1M Prestazione:
-16.27%
6M Prestazione:
-26.13%
1 anno Prestazione:
-31.44%
Codexis Inc Stock (CDXS) Company Profile
Nome
Codexis Inc
Settore
Industria
Telefono
650-421-8100
Indirizzo
200 PENOBSCOT DRIVE, REDWOOD CITY, CA
Confronta CDXS con altri titoli
Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
---|---|---|---|---|---|---|
![]()
CDXS
Codexis Inc
|
2.29 | 189.70M | 70.14M | -76.24M | -57.06M | -1.11 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
484.01 | 124.29B | 11.02B | -535.60M | -978.00M | -2.20 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
610.64 | 66.76B | 14.20B | 4.41B | 3.54B | 38.28 |
![]()
ARGX
Argen X Se Adr
|
590.06 | 35.99B | 2.19B | 833.04M | -1.28B | 12.71 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
262.16 | 33.93B | 2.25B | -278.16M | -42.59M | -2.17 |
![]()
ONC
Beigene Ltd Adr
|
264.32 | 28.47B | 3.81B | -644.79M | -669.77M | -6.24 |
Codexis Inc Stock (CDXS) Upgrades & Downgrades
Data | Azione | Analista | Modifica della valutazione |
---|---|---|---|
2024-08-19 | Downgrade | The Benchmark Company | Buy → Hold |
2024-06-03 | Ripresa | Jefferies | Buy |
2024-05-30 | Iniziato | Cantor Fitzgerald | Overweight |
2024-02-29 | Aggiornamento | The Benchmark Company | Hold → Buy |
2023-11-07 | Downgrade | The Benchmark Company | Buy → Hold |
2023-08-07 | Downgrade | TD Cowen | Outperform → Market Perform |
2023-05-09 | Downgrade | H.C. Wainwright | Buy → Neutral |
2022-03-31 | Ripresa | Piper Sandler | Overweight |
2022-03-02 | Ripresa | Cowen | Outperform |
2021-04-12 | Iniziato | Piper Sandler | Overweight |
2021-03-01 | Iniziato | Stifel | Buy |
2021-02-26 | Reiterato | H.C. Wainwright | Buy |
2020-03-10 | Iniziato | The Benchmark Company | Buy |
2019-01-17 | Aggiornamento | First Analysis Sec | Neutral → Outperform |
2018-05-16 | Iniziato | Stephens | Overweight |
2017-10-13 | Reiterato | H.C. Wainwright | Buy |
2017-05-31 | Iniziato | Jefferies | Buy |
2017-01-26 | Downgrade | First Analysis Sec | Overweight → Equal-Weight |
2017-01-04 | Aggiornamento | Ladenburg Thalmann | Neutral → Buy |
2016-01-06 | Iniziato | H.C. Wainwright | Buy |
Mostra tutto
Codexis Inc Borsa (CDXS) Ultime notizie
Codexis sees significant stock purchase by Opaleye Management, Inc. for $271,788 - Investing.com South Africa
Codexis stock hits 52-week low at $2.43 amid market challenges - Investing.com Australia
Protein Engineering Market Is Booming So Rapidly | Major Giants Merck KGaA, Agilent Technologies, Codexis - newstrail.com
Codexis Appoints Cynthia Collins to Board of Directors - GlobeNewswire
RNA Pioneer and Former Editas CEO Joins Codexis Board: Strategic Move for RNA Therapeutics Push - Stock Titan
Codexis appoints new independent board member By Investing.com - Investing.com Canada
Charles Schwab Investment Management Inc. Purchases 26,052 Shares of Codexis, Inc. (NASDAQ:CDXS) - Defense World
Codexis appoints new independent board member - Investing.com
Codexis, Inc. (NASDAQ:CDXS) Stocks Pounded By 27% But Not Lagging Industry On Growth Or Pricing - simplywall.st
Codexis, Inc. (NASDAQ:CDXS) Holdings Increased by Bank of New York Mellon Corp - Defense World
Codexis sees $236,283 in stock purchases by Opaleye management - Investing.com Australia
Opaleye Management Inc. Expands Stake in Codexis Inc. - GuruFocus
Codexis Announces First Revenue-Generating Contract for ECO Synthesis™ Manufacturing Services - GlobeNewswire
New Contract Propels Codexis (CDXS) Stock Upward, Signaling Market Optimism - Stocks Telegraph
Codexis Signs First Contract for ECO Synthesis Manufacturing Services -March 24, 2025 at 08:17 am EDT - MarketScreener
Codexis Inc (NASDAQ: CDXS): Should Value Hunters Buy It? - Stocks Register
Codexis Achieves Major Revenue Milestone: First ECO Synthesis Contract Signals Market Breakthrough - StockTitan
Opaleye Management Inc. Increases Stake in Codexis Inc. - GuruFocus
Codexis stock hits 52-week low at $2.47 amid market challenges By Investing.com - Investing.com South Africa
Codexis stock hits 52-week low at $2.47 amid market challenges - Investing.com India
Opaleye Management Inc. Boosts Investment in Codexis with Major Stock Purchase - TipRanks
Cantor Fitzgerald Lowers Earnings Estimates for Codexis - Defense World
Codexis sees $261,350 stock acquisition by Opaleye management - Investing.com Australia
Codexis sees $261,350 stock acquisition by Opaleye management By Investing.com - Investing.com South Africa
Stocks of Codexis Inc (CDXS) are poised to climb above their peers - SETE News
Major Shareholder Makes Bold Move with Codexis Stock Purchase! - TipRanks
Codexis Inc (CDXS) Q1 2024 Earnings Call Transcript Highlights: Strong Revenue Growth and Strategic Advances - GuruFocus.com
Rhumbline Advisers Boosts Stock Holdings in Codexis, Inc. (NASDAQ:CDXS) - Defense World
Codexis Announces New Employment Inducement Grants - GlobeNewswire
Codexis grants equity to new hires under inducement plan - Investing.com India
New Hires at Codexis Receive Significant Equity Compensation Package - StockTitan
FY2025 EPS Estimates for Codexis Raised by Cantor Fitzgerald - Defense World
Codexis sees $172,273 stock purchase by Opaleye management - Investing.com
Codexis sees $172,273 stock purchase by Opaleye management By Investing.com - Investing.com South Africa
Things To Consider Before Buying Codexis Inc (NASDAQ: CDXS) - Stocks Register
Codexis at TD Cowen Conference: Enzymatic Innovation in siRNA Manufacturing - Investing.com
This trade activity should not be overlooked: Codexis Inc (CDXS) - SETE News
Codexis stock touches 52-week low at $2.55 amid market challenges - Investing.com Australia
Codexis Inc: Is CDXS Stock Worth Buying? - Stocks Register
Investor Network: Codexis, Inc. to Host Earnings Call - ACCESS Newswire
Top 5 Synthetic Biology Public Companies (March 2025) - Securities.io
Codexis (NASDAQ:CDXS investor three-year losses grow to 84% as the stock sheds US$93m this past week - Simply Wall St
When Will Codexis, Inc. (NASDAQ:CDXS) Become Profitable? - Yahoo Finance UK
Codexis Inc (CDXS) Q4 2024 Earnings Call Highlights: Strategic P - GuruFocus.com
Codexis Inc Azioni (CDXS) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):